title: [How to treat well differentiated endocrine carcinoma with a high proliferative index? A case of gastric endocrine carcinoma].
authors.forename: Carmen
authors.initials: C
authors.lastname: Stefanescu
authors.forename: Nicolas
authors.initials: N
authors.lastname: Mathieu
authors.forename: Nadia
authors.initials: N
authors.lastname: Bouarioua
authors.forename: Adjé
authors.initials: A
authors.lastname: Abbey-Toby
authors.forename: Pascale
authors.initials: P
authors.lastname: Karila Cohen
authors.forename: Denis
authors.initials: D
authors.lastname: Chosidow
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Soulé
authors.forename: Thomas
authors.initials: T
authors.lastname: Aparicio
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D018358:Neuroendocrine Tumors / Q000175:diagnosis / Q000188:drug therapy*; D013274:Stomach Neoplasms / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D005047:Etoposide; D016190:Carboplatin; D002945:Cisplatin